カテゴリー：世界, 医療/バイオ, LP Information

世界の豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチン市場予測 2023年-2029年

【英語タイトル】Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Growth 2023-2029
	・商品コード：LP23DC01164 ・発行会社（調査会社）：LP Information ・発行日：2023年11月・ページ数：115 ・レポート言語：英語・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日）・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など・産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,660 ⇒換算￥556,320	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,490 ⇒換算￥834,480	見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）	USD7,320 ⇒換算￥1,112,640	見積依頼/購入/質問フォーム

※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）

❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチン市場」は、過去の販売実績から2022年の世界の豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチンの総販売量を検討し、2023年から2029年の予測される豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチンの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチンの市場規模を掲載し、XXX百万米ドル規模の世界の豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチン市場の詳細な分析を提供します。本インサイトレポートは、世界の豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチン業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチン市場における各社の独自のポジションをより深く理解するために、豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチン製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチン市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチンの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチンの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチンのヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチンの世界主要メーカーとしては、Zoetis Animal Health、 Boehringer-Ingelheim、 Merck Animal Health、 Ceva Santé Animale、 MSD Animal Health、 SPAH、 Nanjing Tianbang Biological Technology、 Sichuan Huapai Bio-pharmaceutical、 Guangdong Winsun Bio Pharmaceutical、 Wuhan Keqian Biology、 Shanghai Hile Bio-Technology、 Harbin Pharmaceutical Group Bio-Vaccine、 Ringpu、 Shandong Huahong Bioengineering、 Weike Biotechnology、 Nanjing Tianbang Biological Technology、 China Animal Husbandry Industryなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチン市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチン市場をセグメンテーションし、種類別 (生ワクチン、不活化ワクチン)、用途別 (子豚、成豚)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：生ワクチン、不活化ワクチン

・用途別区分：子豚、成豚

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチン市場の10年間の市場状況・展望は？
・世界および地域別に見た豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチン市場成長の要因は何か？
・豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチンの市場機会はエンドマーケットの規模によってどのように変化するのか？
・豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチンのタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチンの年間販売量2018-2029、地域別現状・将来分析
・豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチンの種類別セグメント：生ワクチン、不活化ワクチン
・豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチンの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチンの用途別セグメント：子豚、成豚
・豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチンの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチン市場
・企業別のグローバル豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチン市場データ：2018-2023年の年間販売量、市場シェア
・企業別の豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチンの年間売上：2018-2023年の売上、市場シェア
・企業別の豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチン販売価格
・主要企業の豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチン生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチンの地域別レビュー
・地域別の豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチン市場規模2018-2023：年間販売量、売上
・主要国別の豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチン市場規模2018-2023：年間販売量、売上
・南北アメリカの豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチン販売の成長
・アジア太平洋の豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチン販売の成長
・ヨーロッパの豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチン販売の成長
・中東・アフリカの豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチン販売の成長

南北アメリカ市場
・南北アメリカの国別の豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチン販売量、売上（2018-2023）
・南北アメリカの豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチンの種類別販売量
・南北アメリカの豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチンの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチン販売量、売上（2018-2023）
・アジア太平洋の豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチンの種類別販売量
・アジア太平洋の豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチンの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチン販売量、売上（2018-2023）
・ヨーロッパの豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチンの種類別販売量
・ヨーロッパの豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチンの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチン販売量、売上（2018-2023）
・中東・アフリカの豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチンの種類別販売量
・中東・アフリカの豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチンの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチンの製造コスト構造分析
・豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチンの製造プロセス分析
・豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチンの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチンの主要なグローバル販売業者
・豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチンの主要なグローバル顧客

地域別の豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチン市場予測レビュー
・地域別の豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチン市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチンの種類別市場規模予測
・豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチンの用途別市場規模予測

主要企業分析
Zoetis Animal Health、 Boehringer-Ingelheim、 Merck Animal Health、 Ceva Santé Animale、 MSD Animal Health、 SPAH、 Nanjing Tianbang Biological Technology、 Sichuan Huapai Bio-pharmaceutical、 Guangdong Winsun Bio Pharmaceutical、 Wuhan Keqian Biology、 Shanghai Hile Bio-Technology、 Harbin Pharmaceutical Group Bio-Vaccine、 Ringpu、 Shandong Huahong Bioengineering、 Weike Biotechnology、 Nanjing Tianbang Biological Technology、 China Animal Husbandry Industry
・企業情報
・豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチン製品
・豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチン販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine players cover Zoetis Animal Health, Boehringer-Ingelheim, Merck Animal Health, Ceva Santé Animale, MSD Animal Health, SPAH, Nanjing Tianbang Biological Technology, Sichuan Huapai Bio-pharmaceutical and Guangdong Winsun Bio Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Porcine viral diarrhea is a common and frequently-occurring disease in pigs, and the most serious pathogens are porcine transmissible gastroenteritis virus (TGEV), porcine epidemic diarrhea virus (PEDV) and porcine rotavirus (PoRV). All three pathogens can infect pigs of all ages and can cause symptoms such as vomiting, watery diarrhea and dehydration. The harm to piglets within 10 days of age is particularly serious, and the morbidity and mortality are high, up to 100%. The vaccine is inoculated at the Houhai point, and it is safe and effective for all pigs including suckling piglets and pregnant sows. It realizes the prevention of three diseases with one shot, reduces the immune stress of pigs, and reduces the labor intensity and breeding of vaccination. cost, and has a significant effect on the prevention of single infection or mixed infection of the three pathogens.
LPI (LP Information)’ newest research report, the “Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Industry Forecast” looks at past sales and reviews total world Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine sales for 2023 through 2029. With Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Live Vaccine
Inactivated Vaccine
Segmentation by application
Piglets
Adults Pigs
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Zoetis Animal Health
Boehringer-Ingelheim
Merck Animal Health
Ceva Santé Animale
MSD Animal Health
SPAH
Nanjing Tianbang Biological Technology
Sichuan Huapai Bio-pharmaceutical
Guangdong Winsun Bio Pharmaceutical
Wuhan Keqian Biology
Shanghai Hile Bio-Technology
Harbin Pharmaceutical Group Bio-Vaccine
Ringpu
Shandong Huahong Bioengineering
Weike Biotechnology
Nanjing Tianbang Biological Technology
China Animal Husbandry Industry
Key Questions Addressed in this Report
What is the 10-year outlook for the global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine market?
What factors are driving Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine market opportunities vary by end market size?
How does Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine by Country/Region, 2018, 2022 & 2029
2.2 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Segment by Type
2.2.1 Live Vaccine
2.2.2 Inactivated Vaccine
2.3 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Type
2.3.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sale Price by Type (2018-2023)
2.4 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Segment by Application
2.4.1 Piglets
2.4.2 Adults Pigs
2.5 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Application
2.5.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sale Price by Application (2018-2023)
3 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine by Company
3.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Breakdown Data by Company
3.1.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Company (2018-2023)
3.2 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Company (2018-2023)
3.2.2 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sale Price by Company
3.4 Key Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Location Distribution
3.4.2 Players Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine by Geographic Region
4.1 World Historic Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Growth
4.4 APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Growth
4.5 Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Growth
4.6 Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Growth
5 Americas
5.1 Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Country
5.1.1 Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Country (2018-2023)
5.1.2 Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Country (2018-2023)
5.2 Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Type
5.3 Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Region
6.1.1 APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Region (2018-2023)
6.1.2 APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Region (2018-2023)
6.2 APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Type
6.3 APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine by Country
7.1.1 Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Country (2018-2023)
7.1.2 Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Country (2018-2023)
7.2 Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Type
7.3 Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine by Country
8.1.1 Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Type
8.3 Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine
10.3 Manufacturing Process Analysis of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine
10.4 Industry Chain Structure of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Distributors
11.3 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Customer
12 World Forecast Review for Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine by Geographic Region
12.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Size Forecast by Region
12.1.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Forecast by Region (2024-2029)
12.1.2 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Forecast by Type
12.7 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Forecast by Application
13 Key Players Analysis
13.1 Zoetis Animal Health
13.1.1 Zoetis Animal Health Company Information
13.1.2 Zoetis Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
13.1.3 Zoetis Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Zoetis Animal Health Main Business Overview
13.1.5 Zoetis Animal Health Latest Developments
13.2 Boehringer-Ingelheim
13.2.1 Boehringer-Ingelheim Company Information
13.2.2 Boehringer-Ingelheim Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
13.2.3 Boehringer-Ingelheim Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Boehringer-Ingelheim Main Business Overview
13.2.5 Boehringer-Ingelheim Latest Developments
13.3 Merck Animal Health
13.3.1 Merck Animal Health Company Information
13.3.2 Merck Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
13.3.3 Merck Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Merck Animal Health Main Business Overview
13.3.5 Merck Animal Health Latest Developments
13.4 Ceva Santé Animale
13.4.1 Ceva Santé Animale Company Information
13.4.2 Ceva Santé Animale Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
13.4.3 Ceva Santé Animale Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Ceva Santé Animale Main Business Overview
13.4.5 Ceva Santé Animale Latest Developments
13.5 MSD Animal Health
13.5.1 MSD Animal Health Company Information
13.5.2 MSD Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
13.5.3 MSD Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 MSD Animal Health Main Business Overview
13.5.5 MSD Animal Health Latest Developments
13.6 SPAH
13.6.1 SPAH Company Information
13.6.2 SPAH Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
13.6.3 SPAH Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 SPAH Main Business Overview
13.6.5 SPAH Latest Developments
13.7 Nanjing Tianbang Biological Technology
13.7.1 Nanjing Tianbang Biological Technology Company Information
13.7.2 Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
13.7.3 Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Nanjing Tianbang Biological Technology Main Business Overview
13.7.5 Nanjing Tianbang Biological Technology Latest Developments
13.8 Sichuan Huapai Bio-pharmaceutical
13.8.1 Sichuan Huapai Bio-pharmaceutical Company Information
13.8.2 Sichuan Huapai Bio-pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
13.8.3 Sichuan Huapai Bio-pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Sichuan Huapai Bio-pharmaceutical Main Business Overview
13.8.5 Sichuan Huapai Bio-pharmaceutical Latest Developments
13.9 Guangdong Winsun Bio Pharmaceutical
13.9.1 Guangdong Winsun Bio Pharmaceutical Company Information
13.9.2 Guangdong Winsun Bio Pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
13.9.3 Guangdong Winsun Bio Pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Guangdong Winsun Bio Pharmaceutical Main Business Overview
13.9.5 Guangdong Winsun Bio Pharmaceutical Latest Developments
13.10 Wuhan Keqian Biology
13.10.1 Wuhan Keqian Biology Company Information
13.10.2 Wuhan Keqian Biology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
13.10.3 Wuhan Keqian Biology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Wuhan Keqian Biology Main Business Overview
13.10.5 Wuhan Keqian Biology Latest Developments
13.11 Shanghai Hile Bio-Technology
13.11.1 Shanghai Hile Bio-Technology Company Information
13.11.2 Shanghai Hile Bio-Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
13.11.3 Shanghai Hile Bio-Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Shanghai Hile Bio-Technology Main Business Overview
13.11.5 Shanghai Hile Bio-Technology Latest Developments
13.12 Harbin Pharmaceutical Group Bio-Vaccine
13.12.1 Harbin Pharmaceutical Group Bio-Vaccine Company Information
13.12.2 Harbin Pharmaceutical Group Bio-Vaccine Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
13.12.3 Harbin Pharmaceutical Group Bio-Vaccine Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Harbin Pharmaceutical Group Bio-Vaccine Main Business Overview
13.12.5 Harbin Pharmaceutical Group Bio-Vaccine Latest Developments
13.13 Ringpu
13.13.1 Ringpu Company Information
13.13.2 Ringpu Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
13.13.3 Ringpu Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Ringpu Main Business Overview
13.13.5 Ringpu Latest Developments
13.14 Shandong Huahong Bioengineering
13.14.1 Shandong Huahong Bioengineering Company Information
13.14.2 Shandong Huahong Bioengineering Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
13.14.3 Shandong Huahong Bioengineering Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Shandong Huahong Bioengineering Main Business Overview
13.14.5 Shandong Huahong Bioengineering Latest Developments
13.15 Weike Biotechnology
13.15.1 Weike Biotechnology Company Information
13.15.2 Weike Biotechnology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
13.15.3 Weike Biotechnology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Weike Biotechnology Main Business Overview
13.15.5 Weike Biotechnology Latest Developments
13.16 Nanjing Tianbang Biological Technology
13.16.1 Nanjing Tianbang Biological Technology Company Information
13.16.2 Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
13.16.3 Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Nanjing Tianbang Biological Technology Main Business Overview
13.16.5 Nanjing Tianbang Biological Technology Latest Developments
13.17 China Animal Husbandry Industry
13.17.1 China Animal Husbandry Industry Company Information
13.17.2 China Animal Husbandry Industry Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
13.17.3 China Animal Husbandry Industry Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 China Animal Husbandry Industry Main Business Overview
13.17.5 China Animal Husbandry Industry Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Live Vaccine
Table 4. Major Players of Inactivated Vaccine
Table 5. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Type (2018-2023) & (K Doses)
Table 6. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Type (2018-2023)
Table 7. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Type (2018-2023) & ($ million)
Table 8. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Type (2018-2023)
Table 9. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sale Price by Type (2018-2023) & (US$/Dose)
Table 10. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Application (2018-2023) & (K Doses)
Table 11. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Application (2018-2023)
Table 12. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Application (2018-2023)
Table 13. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Application (2018-2023)
Table 14. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sale Price by Application (2018-2023) & (US$/Dose)
Table 15. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Company (2018-2023) & (K Doses)
Table 16. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Company (2018-2023)
Table 17. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Company (2018-2023)
Table 19. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sale Price by Company (2018-2023) & (US$/Dose)
Table 20. Key Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Producing Area Distribution and Sales Area
Table 21. Players Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Products Offered
Table 22. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Geographic Region (2018-2023) & (K Doses)
Table 26. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share Geographic Region (2018-2023)
Table 27. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Country/Region (2018-2023) & (K Doses)
Table 30. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Country/Region (2018-2023)
Table 31. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Country (2018-2023) & (K Doses)
Table 34. Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Country (2018-2023)
Table 35. Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Country (2018-2023)
Table 37. Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Type (2018-2023) & (K Doses)
Table 38. Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Application (2018-2023) & (K Doses)
Table 39. APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Region (2018-2023) & (K Doses)
Table 40. APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Region (2018-2023)
Table 41. APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Region (2018-2023)
Table 43. APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Type (2018-2023) & (K Doses)
Table 44. APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Application (2018-2023) & (K Doses)
Table 45. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Country (2018-2023) & (K Doses)
Table 46. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Country (2018-2023)
Table 47. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Country (2018-2023)
Table 49. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Type (2018-2023) & (K Doses)
Table 50. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Application (2018-2023) & (K Doses)
Table 51. Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Country (2018-2023) & (K Doses)
Table 52. Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Type (2018-2023) & (K Doses)
Table 56. Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Application (2018-2023) & (K Doses)
Table 57. Key Market Drivers & Growth Opportunities of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine
Table 58. Key Market Challenges & Risks of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine
Table 59. Key Industry Trends of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine
Table 60. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Distributors List
Table 63. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Customer List
Table 64. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Forecast by Region (2024-2029) & (K Doses)
Table 65. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Forecast by Country (2024-2029) & (K Doses)
Table 67. Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Forecast by Region (2024-2029) & (K Doses)
Table 69. APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Forecast by Country (2024-2029) & (K Doses)
Table 71. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Forecast by Country (2024-2029) & (K Doses)
Table 73. Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Forecast by Type (2024-2029) & (K Doses)
Table 75. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Forecast by Application (2024-2029) & (K Doses)
Table 77. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Zoetis Animal Health Basic Information, Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Zoetis Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
Table 80. Zoetis Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 81. Zoetis Animal Health Main Business
Table 82. Zoetis Animal Health Latest Developments
Table 83. Boehringer-Ingelheim Basic Information, Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Boehringer-Ingelheim Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
Table 85. Boehringer-Ingelheim Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 86. Boehringer-Ingelheim Main Business
Table 87. Boehringer-Ingelheim Latest Developments
Table 88. Merck Animal Health Basic Information, Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Merck Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
Table 90. Merck Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 91. Merck Animal Health Main Business
Table 92. Merck Animal Health Latest Developments
Table 93. Ceva Santé Animale Basic Information, Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Ceva Santé Animale Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
Table 95. Ceva Santé Animale Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 96. Ceva Santé Animale Main Business
Table 97. Ceva Santé Animale Latest Developments
Table 98. MSD Animal Health Basic Information, Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. MSD Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
Table 100. MSD Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 101. MSD Animal Health Main Business
Table 102. MSD Animal Health Latest Developments
Table 103. SPAH Basic Information, Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. SPAH Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
Table 105. SPAH Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 106. SPAH Main Business
Table 107. SPAH Latest Developments
Table 108. Nanjing Tianbang Biological Technology Basic Information, Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
Table 110. Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 111. Nanjing Tianbang Biological Technology Main Business
Table 112. Nanjing Tianbang Biological Technology Latest Developments
Table 113. Sichuan Huapai Bio-pharmaceutical Basic Information, Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Sichuan Huapai Bio-pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
Table 115. Sichuan Huapai Bio-pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 116. Sichuan Huapai Bio-pharmaceutical Main Business
Table 117. Sichuan Huapai Bio-pharmaceutical Latest Developments
Table 118. Guangdong Winsun Bio Pharmaceutical Basic Information, Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. Guangdong Winsun Bio Pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
Table 120. Guangdong Winsun Bio Pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 121. Guangdong Winsun Bio Pharmaceutical Main Business
Table 122. Guangdong Winsun Bio Pharmaceutical Latest Developments
Table 123. Wuhan Keqian Biology Basic Information, Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 124. Wuhan Keqian Biology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
Table 125. Wuhan Keqian Biology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 126. Wuhan Keqian Biology Main Business
Table 127. Wuhan Keqian Biology Latest Developments
Table 128. Shanghai Hile Bio-Technology Basic Information, Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 129. Shanghai Hile Bio-Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
Table 130. Shanghai Hile Bio-Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 131. Shanghai Hile Bio-Technology Main Business
Table 132. Shanghai Hile Bio-Technology Latest Developments
Table 133. Harbin Pharmaceutical Group Bio-Vaccine Basic Information, Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 134. Harbin Pharmaceutical Group Bio-Vaccine Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
Table 135. Harbin Pharmaceutical Group Bio-Vaccine Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 136. Harbin Pharmaceutical Group Bio-Vaccine Main Business
Table 137. Harbin Pharmaceutical Group Bio-Vaccine Latest Developments
Table 138. Ringpu Basic Information, Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 139. Ringpu Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
Table 140. Ringpu Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 141. Ringpu Main Business
Table 142. Ringpu Latest Developments
Table 143. Shandong Huahong Bioengineering Basic Information, Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 144. Shandong Huahong Bioengineering Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
Table 145. Shandong Huahong Bioengineering Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 146. Shandong Huahong Bioengineering Main Business
Table 147. Shandong Huahong Bioengineering Latest Developments
Table 148. Weike Biotechnology Basic Information, Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 149. Weike Biotechnology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
Table 150. Weike Biotechnology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 151. Weike Biotechnology Main Business
Table 152. Weike Biotechnology Latest Developments
Table 153. Nanjing Tianbang Biological Technology Basic Information, Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 154. Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
Table 155. Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 156. Nanjing Tianbang Biological Technology Main Business
Table 157. Nanjing Tianbang Biological Technology Latest Developments
Table 158. China Animal Husbandry Industry Basic Information, Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 159. China Animal Husbandry Industry Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolios and Specifications
Table 160. China Animal Husbandry Industry Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 161. China Animal Husbandry Industry Main Business
Table 162. China Animal Husbandry Industry Latest Developments
List of Figures
Figure 1. Picture of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine
Figure 2. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Growth Rate 2018-2029 (K Doses)
Figure 7. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Live Vaccine
Figure 10. Product Picture of Inactivated Vaccine
Figure 11. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Type in 2022
Figure 12. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Type (2018-2023)
Figure 13. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumed in Piglets
Figure 14. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market: Piglets (2018-2023) & (K Doses)
Figure 15. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumed in Adults Pigs
Figure 16. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market: Adults Pigs (2018-2023) & (K Doses)
Figure 17. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Application (2022)
Figure 18. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Application in 2022
Figure 19. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market by Company in 2022 (K Doses)
Figure 20. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Company in 2022
Figure 21. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Company in 2022
Figure 23. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales 2018-2023 (K Doses)
Figure 26. Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue 2018-2023 ($ Millions)
Figure 27. APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales 2018-2023 (K Doses)
Figure 28. APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue 2018-2023 ($ Millions)
Figure 29. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales 2018-2023 (K Doses)
Figure 30. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales 2018-2023 (K Doses)
Figure 32. Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue 2018-2023 ($ Millions)
Figure 33. Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Country in 2022
Figure 34. Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Country in 2022
Figure 35. Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Type (2018-2023)
Figure 36. Americas Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Application (2018-2023)
Figure 37. United States Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Region in 2022
Figure 42. APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Regions in 2022
Figure 43. APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Type (2018-2023)
Figure 44. APAC Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Application (2018-2023)
Figure 45. China Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Country in 2022
Figure 53. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Country in 2022
Figure 54. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Type (2018-2023)
Figure 55. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Application (2018-2023)
Figu

★調査レポート[世界の豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチン市場予測 2023年-2029年] (コード：LP23DC01164)販売に関する免責事項を必ずご確認ください。

★調査レポート[世界の豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチン市場予測 2023年-2029年]についてメールでお問い合わせ

MarketReport.jp

世界の豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチン市場予測 2023年-2029年

市場調査レポート・産業資料総合販売サイト www.MarketReport.jp

市場調査レポート・産業資料 総合販売サイト www.MarketReport.jp

市場調査レポート・産業資料総合販売サイト www.MarketReport.jp